Mental disorders represent a worldwide public health concern. Psychotherapies and
pharmacotherapies are recommended as first line treatments. However, evidence has …

In the past, little or no attention was paid to cognitive disorders associated with depression
(a condition sometimes termed pseudodementia). However, recent years have seen a …

Individuals with substance use disorders (SUDs) are at increased risk for COVID‐19
infection and for adverse outcomes of the infection. Though vaccines are highly effective …

Being different multifactorial forms of psychopathology, aggression, depression and suicidal
behavior, which is considered to be violent aggression directed against the self, have …

Depression is common in older adults and those with cardiovascular disease. Although
selective serotonin reuptake inhibitors generally have been shown to be safe to treat …

Objectives: Vortioxetine has already shown its efficacy in the acute and long-term treatment
of major depressive disorder (MDD) and its potential interest in the prevention of relapse …

In recent years, there has been a significant increase in depression, which is related to,
among other things, the COVID-19 pandemic. Depression can be fatal if not treated or if …

Given the role of low-grade inflammation in the pathophysiology of major depressive
disorder (MDD), anti-inflammatory strategies may improve treatment outcomes in some …

Depression is a common and heterogeneous condition with a chronic and recurrent natural
course that is frequently seen in the primary care setting. Primary care providers play a …

Depression and anxiety are the most frequent neuropsychiatric symptoms of multiple
sclerosis (MS), an autoimmune-mediated demyelinating neurodegenerative disease. Their …